US FDA grants breakthrough therapy designation to Avidity Biosciences’ delpacibart etedesiran to treat myotonic dystrophy type 1: San Diego Friday, May 10, 2024, 14:00 Hrs [IST] ...
Minghui Pharma to present phase I/II study results of MHB088C to treat patients with recurrent or metastatic solid tumors at ASCO meeting: Shanghai Friday, May 10, 2024, 18:00 Hrs ...
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AßOs) for the treatment of Alzheimer’s ...
ENA Respiratory receives US patent covering INNA-051, a first-in-class antiviral innate immunomodulator: Melbourne, Australia Friday, May 10, 2024, 15:00 Hrs [IST] ENA Respiratory ...
Shanghai Friday, May 10, 2024, 17:00 Hrs [IST] Andall Biosciences Inc (ABI), a renowned biotechnology company at the forefr ...
ExcellGene collaborates with Cytovance Biologics to transform large molecule biologics development and production: Oklahoma City Friday, May 10, 2024, 11:00 Hrs [IST] ExcellGene S ...
OJSP launches Sudhamukti ayurvedic medicine for diabetes management: Our Bureau, Mumbai Friday, May 10, 2024, 13:30 Hrs [IST] OJSP has launched Sudhamukti ayurvedic medicine, a br ...
Recce Pharmaceuticals Ltd, a company developing new class of synthetic anti-infectives designed to address the urgent global health problems of antibiotic-resistant superbugs and emerging viral ...
NIH to launch long Covid trials to study sleep disturbances, exercise intolerance, and post exertional malaise: Bethesda, Maryland Friday, May 10, 2024, 10:00 Hrs [IST] The Nation ...
Omron Healthcare India, the Indian arm of the Japanese global leader in medical equipment for home health monitoring and treatment, has announced its collaboration with AliveCor India, the Indian ...
Bayer will present detailed results from the pivotal phase III studies OASIS 1 and 2 evaluating the efficacy and safety of the investigational compound elinzanetant versus placebo, at the upcoming ...
Experts advocate amendment to DMR Act, imposing substantial penalties for non-compliance: Nandita Vijayasimha, Bengaluru Friday, May 10, 2024, 08:00 Hrs [IST] Arogya Bharati and t ...